<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01526967</url>
  </required_header>
  <id_info>
    <org_study_id>MA-0509-12-U359</org_study_id>
    <nct_id>NCT01526967</nct_id>
  </id_info>
  <brief_title>Observational Evaluation of the Peristomal Skin Condition in Ostomates</brief_title>
  <acronym>OSMOSE</acronym>
  <official_title>Observational Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™ Skin Barriers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ConvaTec Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ConvaTec Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to estimate the incidence and severity of peristomal skin
      lesions and evaluate the progression of the peristomal skin condition at 8-15 days following
      application of the barrier.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peristomal skin condition</measure>
    <time_frame>At day 12</time_frame>
    <description>Change in peristomal skin condition from baseline as assessed with the SACS Instrument</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peristomal skin condition</measure>
    <time_frame>at 1 month</time_frame>
    <description>Change in peristomal skin condition from baseline as assessed with the SACS instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of satisfaction</measure>
    <time_frame>At 2 months</time_frame>
    <description>Subjects satisfaction as measured with a satisfaction survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accessory usage</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Subjects use of additional products in stoma care.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peristomal Skin Condition</measure>
    <time_frame>At 2 months</time_frame>
    <description>Change in peristomal skin condition from baseline as assessed with the SACS instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of satisfaction</measure>
    <time_frame>At 12 days</time_frame>
    <description>Subjects level of satisfaction as measured by a satisfaction survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of satisfaction</measure>
    <time_frame>At 1 month</time_frame>
    <description>Subjects level of satisfaction as measured with a satisfaction survey</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Ostomy</condition>
  <arm_group>
    <arm_group_label>New moldable user</arm_group_label>
    <description>Subjects presenting with peristomal lesions with a traditional barrier and for whom a ConvaTec Moldable Technology™ Skin Barrier is used as a replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>New osomate</arm_group_label>
    <description>Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        colostomates, ileostomates, urostomates in acute care settings or community at large.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are 18 years old and older.

          -  Subjects who agree to participate in the evaluation and who have signed the informed
             consent form.

          -  Subjects presenting with a stoma (ileostomy, colostomy or urostomy).

          -  Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier per package insert is
             used as the first long-term (within 7 days of ostomy surgery) system following surgery
             and have intact peristomal skin.

        OR

          -  Subjects presenting with peristomal skin lesions using a traditional barrier and for
             whom a decision to replace the traditional barrier with ConvaTec Moldable Technology™
             Skin Barrier per package insert is made in the context of routine clinical care.

        Exclusion Criteria:

          -  Subjects who, according to the investigator, have cognitive problems that prevent them
             from answering a questionnaire or for whom the evaluation could be a problem.

          -  Subjects who are in a simultaneous clinical evaluation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qing Li, Ph.D, MD</last_name>
    <role>Study Chair</role>
    <affiliation>ConvaTec Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Independent Nurse Consultant</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85742</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Muir Health Concord Campus</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Conn. Clinical Nursing Associate, LLC</name>
      <address>
        <city>Plymoth</city>
        <state>Connecticut</state>
        <zip>06782</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Home Health</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Porter Hospital</name>
      <address>
        <city>Valparaiso</city>
        <state>Indiana</state>
        <zip>46383</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Serena Group - Dr. Thomas Serena MD</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Macomb Hospital</name>
      <address>
        <city>Clinton Township</city>
        <state>Michigan</state>
        <zip>48038</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karmanos Cancer Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Anthony's Medical Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ID Med Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43222</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RI Colorectal Clinic, LLC</name>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <zip>02860</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Jacinto Methodist Hospital</name>
      <address>
        <city>Baytown</city>
        <state>Texas</state>
        <zip>77521</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NW Pavillion Ostomy Clinic</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Canada</country>
  </removed_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2012</study_first_submitted>
  <study_first_submitted_qc>February 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <last_update_submitted>December 14, 2012</last_update_submitted>
  <last_update_submitted_qc>December 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ostomy</keyword>
  <keyword>peristomal skin breakdown</keyword>
  <keyword>ConvaTec Moldable Skin Barriers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 19, 2014</submitted>
    <returned>April 22, 2014</returned>
    <submitted>March 30, 2016</submitted>
    <returned>May 3, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

